Head-to-head · Value Score
Oak vs bmiMD
Two GLP-1 deals, scored on the same six factors. Oak lands a Value Score of 88, bmiMD a 89. Here's who gives you the honest lower price — and where each one bites back.
Oak
#5 · Grade A · Great Deal
Est. first month
$119/mo
Save ~91% vs brand-namebmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 88 — an est. $99/mo first month, with no teaser step-up baked in. Oak isn't out of it: Bargain hunters who want the lowest sticker price and no recurring commitment.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Oak | bmiMD |
|---|---|---|
| Value Score | 88 (A) | 89 (A) |
| Est. first month | $119/mo | $99/mo |
| Save vs brand-name | ~91% | ~93% |
| Semaglutide | From $119/mo | $99/mo |
| Tirzepatide | From $185/mo | $139/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Oak
The cheapest published prices on the board, with genuinely flat dose pricing and nothing to cancel.
Why it's a deal
- Lowest published prices here — semaglutide from $119/mo, tirzepatide from $185/mo
- One price across every dosage, so titration never raises the bill
- No membership or subscription fee, and free shipping
- All 50 states, offered in Spanish as well as English
The fine print
- Same-day approval with no video call means very little clinical contact before a prescription
- Injection only — no oral or sublingual route, and no brand-name lane
- Sold as packages, so re-ordering is on you
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.